This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Surface here is educational only; do not use without medical supervision. Our editorial verdict is SKIP-FOR-NOW — current cost / risk / redundancy puts it below the line.
Testosterone Cypionate
Testosterone cypionate (Depo-Testosterone) is the US-dominant long-ester injectable testosterone — pharmacologically indistinguishable…
Aliases (5)
Overview
What is Testosterone Cypionate?
Testosterone cypionate is a long-acting injectable ester of testosterone with a half-life of ~8 days, FDA-approved for testosterone replacement therapy in hypogonadal men. It is one of the two most commonly prescribed TRT esters in the US (alongside enanthate).
Key Benefits
Restores serum testosterone in hypogonadism, improves libido, energy, mood, lean mass, bone density, and cognition; the long ester allows once-weekly or twice-weekly dosing for stable levels.
Mechanism of Action
After IM injection, the cypionate ester is slowly hydrolyzed in plasma, releasing free testosterone. Testosterone binds the androgen receptor, drives gene transcription for protein synthesis and male secondary characteristics, and aromatizes peripherally to estradiol for bone and cardiovascular benefits.
Pharmacokinetics
▸ Vial inspection & sterile draw AAS oil
AAS oil arrives pre-suspended in carrier oil — no BAC water needed. Inspect for clarity, color, and crashed compound (cold storage can crystallize). Warm vial in palm or under hot tap before draw.
- 1 Wipe vial stopper with isopropyl alcohol.
- 2 Warm vial 30-60s in palm if oil is cold/cloudy.
- 3 Draw with 18g needle into 22-25g pin barrel for IM, or 27-29g for sub-Q.
- 4 Tap out air bubbles, expel a small drop, then inject at chosen site.
▸ Cycle structure & PCT AAS
Ramp dose over week 1, hold steady through cycle weeks. Track baseline labs (TT/FT/E2/SHBG/HCT/lipids/LFTs) at week 0; recheck at week 4 and end-of-cycle.
On the last dose, the ester clears over its half-life window (cypionate = est. 8 days). PCT begins after the active compound has cleared.
Standard PCT is enclomiphene 12.5-25 mg/day or clomid 50/50/25/25 over 4 weeks (or nolvadex 20/20/10/10). HCG bridge optional during cycle to preserve testicular volume + faster restart. Bloodwork at PCT week 4 + 8 to confirm HPG axis recovery (LH, FSH, TT back to baseline).
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
Manages E2 at supraphysiologic doses. Rarely needed at TRT doses; over-suppression of E2 produces joint pain, low libido, lipid issues — modern TRT trends aw…
Maintains testicular volume + intratesticular T for fertility preservation in younger TRT patients; can be combined with cyp lifelong.
Ironically used DURING cyp in some "stacked" TRT protocols to preserve LH/FSH signal — relatively novel approach.
For hair preservation — blocks 5α-reductase; controversial trade-off (post-finasteride syndrome risk; possibly attenuates anabolic effect in muscle).
Hepatotoxic; redundant + dangerous. See methyltestosterone.md — strictly dominated.
Each adds specific harms (Tren = neuro/CV/sleep nightmare; Deca = prolactin, "deca dick", much longer suppression).
Compounds CV strain (HR + BP + Hct).
Compounds lipid + BP + hepatic load.
Quality Indicators
White, fluffy cake (peptides)
Lyophilized peptide should appear as a white, fluffy "cake" filling most of the vial bottom. Indicates proper freeze-drying.
Clear solution after reconstitution
After mixing with bacteriostatic water, the solution should be crystal clear with no particles or cloudiness.
Slight clumping acceptable
Small clumps that fully dissolve with gentle swirling are normal — shipping can cause minor compaction.
Collapsed or melted powder
Powder that looks collapsed, melted, or stuck to vial sides may have been heat-damaged in transit.
Cloudy or particulate solution
Persistent cloudiness or visible particles after gentle mixing indicate degraded or contaminated material.
What to Expect
- Onset(TRT 100-200 mg/wk): Subtle. Energy, morning erections, sleep, mood improve over 2-6 weeks. Body comp shifts over 3-6 months.
- Onset(supraphysiologic 400-600 mg/wk): Noticeable libido + drive surge within 1-2 weeks, training aggression, faster recovery, water retention, mood lift borderin…
- PeakPlateau by week 4-6. Sustained anabolic effect for cycle duration.
- Taper/ post-cycle: Without PCT, crash 2-3 weeks post-last-injection (one ester half-life clearance). Profound fatigue, libido collapse, depressed mood, fat regain…
Side Effects & Safety
- Common (>10% users at suppressive dose):
- Testicular atrophy (universal at suppressive doses without hCG)
- Decreased spermatogenesis / oligospermia / azoospermia
- Acne, oily skin
- Water retention / edema (E2-mediated)
- Increased hematocrit / hemoglobin (less aggressive than enanthate at equal dose, anecdotally)
- Injection site soreness (PIP — less PIP than propionate, equivalent to enanthate)
- Less common (1-10%):
- Gynecomastia (E2-driven, especially without AI in supra dosing)
- Mood lability / irritability / aggression — variable, dose-dependent
- Sleep apnea worsening
- Accelerated androgenic alopecia (in genetically susceptible — SRD5A2 dependent)
- Lipid panel deterioration (HDL ↓, LDL/ApoB ↑) — typically less severe than oral 17αAA but real
- Cottonseed oil allergy (rare; some compounders use grapeseed or MCT alternatives)
- Rare-serious (<1% but worth knowing):
- Polycythemia → thromboembolic risk (DVT, PE, stroke). Phlebotomy or blood donation if Hct >54%.
- Cardiomyopathy / LVH at chronic supraphysiologic exposure (years).
- Permanent fertility loss — reported even after PCT in some cases. Risk highest with longer cycles, higher doses, age >35, low baseline FSH.
- Prostate hypertrophy / unmasking subclinical prostate cancer.
- Sterile abscess at injection site (poor technique / contaminated UGL gear).
- Hepatic effects: minimal with injectables (vs oral 17αAA like methyltestosterone).
- Specific watch periods:
- First 8-12 weeks: monitor hematocrit, E2, libido response, mood.
- 3 months: full lipid + comprehensive panel.
- Annually: PSA + DRE if >40 or family history.
References
Depo-Testosterone (testosterone cypionate) — FDA label
current FDA prescribing information; PK, dosing, contraindications, drug interactions.
View StudyWADA Prohibited List 2026
S1 exogenous androgen classification (banned in and out of competition).
View StudyTestosterone cypionate — DrugBank DB13943
pharmacology, mechanism, indications, interactions.
View StudyTestosterone cypionate — PubChem CID 5995
chemical structure, CAS 58-20-8.
View StudyHow was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.